The effects of four ellagitannin metabolites (M1-M4) and ellagic acid on immunoglobulin E-mediated allergic responses in rat basophilic leukemia-2H3 cells were investigated. M1-M4 inhibited the antigen-induced degranulation and secretion of interleukin-4 and tumor necrosis factor-, but ellagic acid only slightly did so under the same experimental conditions. M1 inhibited the activation of the mitogen-activated protein kinases in antigen-stimulated cells.
Ellagitannins (ETs) are natural polyphenols abundant in certain fruits and nuts, including pomegranates, raspberries, and walnuts. 1) They are not absorbed in humans, but are hydrolyzed to yield ellagic acid (EA), which is further metabolized by colon microflora to produce ET metabolites (mainly urolithin A).
2) To characterize the chemical structures of ET metabolites, Ito et al.
3) investigated urinary and intestinal microbial metabolites appearing in rats after ingestion of a purified ellagitannin, geraniin. Four (M1-M4) were major metabolites found in serum and urinary excretion in the rat.
3) To our knowledge, no effects of ET metabolites on IgE-mediated allergic responses have been reported. In the present study, we used the rat basophilic leukemia (RBL-2H3) cell line, which has been used extensively as an in vitro model for the study of Fc"RI signaling, to investigate the effects of M1-M4 on IgE-mediated allergic responses in comparison with EA.
M1-M4 were prepared as described previously.
3) EA and quercetin were purchased from Sigma-Aldrich (St. Louis, MO). The polyphenol samples were dissolved in dimethyl sulfoxide (DMSO) for use in the experiments. RBL-2H3 cells were maintained in Dulbecco's Modified Eagle's Medium (Sigma-Aldrich) with 10% (v/v) fetal calf serum, 100 U/mL of penicillin, and 100 mg/mL of streptomycin at 37 C in a humidified atmosphere containing 5% CO 2 .
We measured antigen (Ag)-induced -hexosaminidase release from the RBL-2H3 cells to study the ability of the metabolite compounds to inhibit degranulation activity. The cells were seeded in a 24-well plate (2:5 Â 10 5 /well) and cultured overnight. They were sensitized with DNP-specific IgE at 50 ng/mL for 2 h. After the cells were washed with modified Tyrode (MT) buffer containing 137 mM NaCl, 2.7 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 5.6 mM glucose, 20 mM HEPES, and 0.1% BSA at pH 7.4, polyphenol samples diluted in MT buffer were added. After 10 min of incubation, DNP-HSA (final concentration 50 ng/mL) was added, and the culture was incubated for 30 min. The supernatant was collected, and the cells were lysed with MT buffer containing 0.1% Triton X-100. Aliquots of each supernatant and cell lysate were incubated with 1 mM p-nitrophenyl-N-acetyl--D-glucosamide solubilized in 0.05 M citrate buffer (pH 4.5) for 30 min at 37 C. The enzyme reaction was terminated by the addition of 0.05 M sodium carbonate buffer (pH 10), and the absorbance (at 415 nm) was measured. Figure 1 shows the inhibitory effects of EA, quercetin, and the four ET metabolites on Ag-induced -hexosaminidase release from the cells. Each of the ET metabolites and quercetin significantly and dose-dependently reduced -hexosaminidase release. Ag-induced -hexosaminidase release was inhibited in rank order M3 > M1 > M2, quercetin, M4. The IC 50 values for M1, M2, M3, M4, and quercetin were 2.1, 4.9, 0.7, 5.7, and 4.9 mM, respectively. In contrast, EA only slightly inhibited Ag-inducedhexosaminidase release, by 12 AE 3% at a concentration of 32 mM.
The ET metabolites, but not EA itself, significantly inhibited Ag-induced degranulation in the cells. M1 and M3 showed the strongest inhibitory activity, and quercetin, M2 and M4 had slightly smaller effects. These results are in keeping with previous reports. Itoh et al. 4) reported that EA inhibited Ag-inducedhexosaminidase release from RBL-2H3 cells in a dosedependent manner at concentrations of 5-50 mM, but, in agreement with our own findings, its inhibitory activity was lower than that of quercetin. In addition, Choi and Yan 5) found that oral administration of EA inhibited anti-DNP IgE-mediated passive cutaneous anaphylaxis in rats. These results suggest that the in vivo activity of y To whom correspondence should be addressed. Tel: +81-86-462-1111; Fax: +81-86-463-3508; E-mail: naganot@mw.kawasaki-m.ac.jp Abbreviations: ET, ellagitannin; EA, ellagic acid; RBL, rat basophilic leukemia; IgE, immunoglobulin E; Fc"RI, high-affinity Fc receptor for IgE; Ag, antigen; DNP, 2,4-dinitrophenyl; HSA, human serum albumin; IL-4, interleukin-4; TNF-, tumor necrosis factor-; MAPK, mitogen-activated protein kinase; ERK, extracellular signal-regulated kinase; JNK, c-Jun N-terminal kinase EA on the IgE-mediated degranulation of basophils and mast cells is due to metabolites generated by colon microflora.
We also determined the effects of the four metabolites and EA on the viability of RBL-2H3 cells incubated with the four metabolites and with EA at 32 mM for 24 h. Viability was assessed using an MTT cell proliferation assay kit (Cayman Chemical, Ann Arbor, MI), following the manufacturer's instructions. No significant differences were found (data not shown).
When Ag crosslinks adjacent IgE molecules, aggregation of Fc"RI triggers a complex intracellular signaling process that results in the secretion of allergy-related cytokines.
6) Hence we examined to determine whether ET metabolites and EA can modulate Ag-induced secretion of IL-4 and TNF-in RBL-2H3 cells (Fig. 2) . Cells were seeded into a 24-well culture plate and cultured overnight. They were sensitized with DNPspecific IgE, incubated with 0.1% DMSO (control) or a polyphenol sample in MT buffer, and then challenged with DNP-HAS, as described above. Four h after challenge with DNP-HSA, the supernatant was collected, and cytokine levels were determined by ELISA assay performed following the manufacturer's instructions (R&D Systems, Minneapolis, MN). At a concentration of 2 mM, only M3 significantly decreased IL-4 and TNFproduction in the culture supernatant of the cells. At a higher concentration, 8 mM, IL-4 and TNF-secretion was inhibited by all four metabolites, but not at all by EA. It is likely that the ability to suppress cytokine secretion (Fig. 2) was correlated with the inhibitory effects on RBL-2H3 cell degranulation, as indicated by our studies of -hexosaminidase release (Fig. 1) . In agreement with our results, Choi and Yan 5) found that EA inhibited Ag-induced secretion of pro-inflammatory cytokines in RBL-2H3 cells with only very low potency. EA inhibited the release of TNF-and IL-6 by 69.4% and 57.9% respectively at 100 mM, and by 77.7% and 68.5% respectively at 200 mM.
5) Given our findings that the EA metabolites inhibited cytokine release at much lower concentrations, these results indicate that ET metabolites possess greater inhibitory activity than EA in the modulation of allergy-related cytokine secretion.
In mast cells and basophils, mitogen-activated protein kinases (MAPKs) are activated in pathways leading to degranulation and cytokine expression. 6) We examined the effects of M1 and EA on the phosphorylation of three major members of the MAPK superfamily, extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK), in RBL-2H3 cells by immunoblotting. RBL-2H3 cells were seeded into a sixwell culture plate (1 Â 10 6 cells per well) and cultured overnight. They were sensitized with DNP-specific IgE, incubated with M1 (8 or 32 mM) or EA (32 mM) in MT buffer, and challenged with DNP-HAS, as described above. Five min after challenge, they were lysed by the addition of sodium dodecyl sulfate sample buffer. Western blotting was conducted using sampler kits of MAPK and phospho-MAPK family antibodies (Cell Signaling Technology, Beverly, MA) following the manufacturer's instructions. As Fig. 3 shows, pretreatment with M1 attenuated Ag-induced phosphorylation of ERK1/2, JNK, and p38-MAPK in a concentrationdependent manner. In contrast, EA did not inhibit the phosphorylation of any MAPK at 32 mM. These data support our hypothesis that inhibition of Ag-induced degranulation and cytokine secretion by M1 in RBL-2H3 cells (Figs. 1 and 2) is mediated, at least in part, by inhibition of JNK, ERK, and p38-MAPK pathway activation. In summary, our data provide evidence that bioavailable ET metabolites inhibit IgE-mediated allergic responses in an in vitro model system. Four major metabolites (M1-M4) intensely suppressed Ag-induced degranulation and the secretion of allergy-related cytokines (IL-4 and TNF-) in RBL-2H3 cells. In contrast, EA had little inhibitory effect on degranulation and no effect on cytokine secretion under these assay conditions. It is noteworthy that M1 inhibited the activation of JNK, ERK, and p38-MAPK, suggesting that inhibition of IgE-mediated allergic responses can be mediated by inhibition of MAPK pathways. Further research is warranted to verify these results in vivo, but our results highlight that ET metabolites, generated following dietary consumption of ET-rich foods such as pomegranates and walnuts, may be therapeutically valuable in preventing allergic symptoms by inhibiting mast cell activation. DNP-specific IgE-sensitized RBL-2H3 cells were challenged with DNP-HSA for 5 min. Polyphenols were added 10 min before Ag challenge. Proteins derived from the RBL cells were subjected to Western blotting analysis to detect phosphorylated forms of ERK, p38, and JNK. B, blank (not sensitized with DNP-specific IgE). C, vehicle control to which 0.1% dimethyl sulfoxide was added instead of a polyphenol sample.
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